These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10815633)

  • 1. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker.
    Molteni A; Moulder JE; Cohen EF; Ward WF; Fish BL; Taylor JM; Wolfe LF; Brizio-Molteni L; Veno P
    Int J Radiat Biol; 2000 Apr; 76(4):523-32. PubMed ID: 10815633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis.
    Molteni A; Wolfe LF; Ward WF; Ts'ao CH; Molteni LB; Veno P; Fish BL; Taylor JM; Quintanilla N; Herndon B; Moulder JE
    Curr Pharm Des; 2007; 13(13):1307-16. PubMed ID: 17506716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists.
    Molteni A; Ward WF; Ts'ao CH; Taylor J; Small W; Brizio-Molteni L; Veno PA
    Curr Pharm Des; 2003; 9(9):751-61. PubMed ID: 12570792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817.
    Ward WF; Molteni A; Ts'ao CH
    Radiat Res; 1989 Feb; 117(2):342-50. PubMed ID: 2922477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function analysis of angiotensin-converting enzyme inhibitors as modifiers of radiation-induced pulmonary endothelial dysfunction in rats.
    Ward WF; Molteni A; Kim YT; Ts'ao C
    Br J Radiol; 1989 Apr; 62(736):348-54. PubMed ID: 2540864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation pneumotoxicity in rats: modification by inhibitors of angiotensin converting enzyme.
    Ward WF; Molteni A; Ts'ao CH; Kim YT; Hinz JM
    Int J Radiat Oncol Biol Phys; 1992; 22(3):623-5. PubMed ID: 1735701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.
    Molteni A; Moulder JE; Cohen EP; Fish BL; Taylor JM; Veno PA; Wolfe LF; Ward WF
    Exp Biol Med (Maywood); 2001 Dec; 226(11):1016-23. PubMed ID: 11743137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy.
    Moulder JE; Fish BL; Cohen EP
    Int J Radiat Biol; 1998 Apr; 73(4):415-21. PubMed ID: 9587080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax.
    Kma L; Gao F; Fish BL; Moulder JE; Jacobs ER; Medhora M
    J Radiat Res; 2012; 53(1):10-7. PubMed ID: 22302041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonist.
    Moulder JE; Fish BL; Cohen EP
    Radiother Oncol; 1998 Mar; 46(3):307-15. PubMed ID: 9572624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme.
    Ward WF; Kim YT; Molteni A; Solliday NH
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):135-40. PubMed ID: 3292488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy.
    Moulder JE; Fish BL; Cohen EP
    Curr Pharm Des; 2003; 9(9):737-49. PubMed ID: 12570791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine.
    Molteni A; Ward WF; Ts'ao CH; Solliday NH; Dunne M
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):112-20. PubMed ID: 2994075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation injury in rat lung. IV. Modification by D-penicillamine.
    Ward WF; Molteni A; Ts'ao C; Solliday NH
    Radiat Res; 1984 May; 98(2):397-406. PubMed ID: 6328567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of radiation nephropathy with ACE inhibitors.
    Moulder JE; Fish BL; Cohen EP
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):93-9. PubMed ID: 8365947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis.
    Ghosh SN; Zhang R; Fish BL; Semenenko VA; Li XA; Moulder JE; Jacobs ER; Medhora M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1528-36. PubMed ID: 19931735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs.
    Medhora M; Gao F; Wu Q; Molthen RC; Jacobs ER; Moulder JE; Fish BL
    Radiat Res; 2014 Nov; 182(5):545-55. PubMed ID: 25361399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography.
    Ward WF; Lin PJ; Wong PS; Behnia R; Jalali N
    Radiat Res; 1993 Jul; 135(1):81-7. PubMed ID: 8327665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists.
    Moulder JE; Fish BL; Cohen EP
    Curr Pharm Des; 2007; 13(13):1317-25. PubMed ID: 17506717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.